Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Kazem, H. Asl, M. Avijgan, M. Mohamadnejad (2004)
HIGH PREVALENCE OF HBV, HCV, AND HIV INFECTIONS IN GYPSY POPULATION RESIDING IN SHAHR-E-KORD
K. Stark, U. Bienzle, R. Vonk, I. Guggenmoos‐Holzmann (1997)
History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.International journal of epidemiology, 26 6
(2014)
HIV infection and risk, prevention, and testing behaviors among injecting drug users-National HIV behavioral surveillance system, 20 US Cities
M. Burattini, Eduardo Massad, M. Rozman, R. Azevedo, H. Carvalho (2000)
Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison.Revista de saude publica, 34 5
S. Shrestha, D. Shrestha, T. Gafney, K. Maharjan, F. Tsuda, H. Okamoto (1996)
Hepatitis B and C infection among drug abusers in Nepal.Tropical gastroenterology : official journal of the Digestive Diseases Foundation, 17 4
D. Jarlais, K. Arasteh, J. Feelemyer, C. McKnight, David Barnes, S. Tross, D. Perlman, A. Campbell, H. Cooper, H. Hagan (2016)
From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.Journal of substance abuse treatment, 71
E. Razzaghi, A. Movaghar, Traci Green, K. Khoshnood (2006)
Profiles of risk: a qualitative study of injecting drug users in Tehran, IranHarm Reduction Journal, 3
M. Saha, S. Chakrabarti, S. Panda, T. Naik, B. Manna, A. Chatterjee, R. Detels, Bhattacharya Sk (2000)
Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India.The Indian journal of medical research, 111
J. Textor, J. Hardt, S. Knüppel (2011)
DAGitty: a graphical tool for analyzing causal diagrams.Epidemiology, 22 5
Indian Journal of Medical Research, 111
E. Khoei, M. Jamshidimanesh, M. Emamian, Fatemeh Sheikhan, K. Dolan, K. Brady (2018)
Veiled Truths: Iranian Women and Risky Sexual Behavior in the Context of Substance UseJournal of Reproduction & Infertility, 19
A. Buavirat, K. Page-Shafer, G. Griensven, Jeffrey Mandel, Jennifer Evans, J. Chuaratanaphong, S. Chiamwongpat, Rachel Sacks, Moss Ar (2003)
Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control studyBMJ : British Medical Journal, 326
S. Tortu, J. McMahon, R. Hamid, A. Neaigus (2003)
Women's Drug Injection Practices in East Harlem: An Event Analysis in a High-Risk CommunityAIDS and Behavior, 7
E. Focà, Paola Magro, D. Motta, S. Compostella, S. Casari, A. Bonito, N. Brianese, A. Ferraresi, P. Rodari, M. Pezzoli, E. Quiros-Roldan, F. Castelli (2016)
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern ItalyInternational Journal of Molecular Sciences, 17
Toby Lea, L. Mao, N. Bath, G. Prestage, I. Zablotska, J. Wit, M. Holt (2013)
Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infectionAIDS and Behavior, 17
S. Alavian, B. Gholami, Sadegh Masarrat (2002)
Hepatitis C risk factors in Iranian volunteer blood donors: A case–control studyJournal of Gastroenterology and Hepatology, 17
M. Samuel, P. Doherty, M. Bulterys, S. Jenison (2001)
Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USAEpidemiology and Infection, 127
M. Zali, M. Kazem, A. Nourbala, B. Nayer, S. Shahraz (2005)
Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran.Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 11 1-2
C. Brouard, A. Gautier, L. Saboni, C. Jestin, C. Semaille, N. Beltzer (2013)
Hepatitis B knowledge, perceptions and practices in the French general population: the room for improvementBMC Public Health, 13
T. Fuglsang, J. Fouchard, P. Ege (2000)
[Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].Ugeskrift for laeger, 162 27
L. Ghahremani, E. Zarei, Hosein Moltafet, A. Asadollahi (2018)
Data on hepatitis B, C signs, and HIV-aids among middle-aged and older IDUs in Southwest IranData in Brief, 17
F. Shahbazi, S. Mirtorabi, M. Ghadirzadeh, S. Hashemi-Nazari, Abdolrazagh Barzegar (2017)
Characterizing Mortality from Substance Abuse in Iran: An Epidemiological Study during March 2014 to February 2015Addiction & Health, 9
Chiyu Zhang, Rongge Yang, X. Xia, Shaoying Qin, Jianping Dai, Zunbin Zhang, Z. Peng, Tong-jian Wei, Hui Liu, Decheng Pu, Jianhua Luo, Y. Takebe, K. Ben (2002)
High Prevalence of HIV‐1 and Hepatitis C Virus Coinfection Among Injection Drug Users in the Southeastern Region of Yunnan, ChinaJAIDS Journal of Acquired Immune Deficiency Syndromes, 29
M. Baratvand, M. Soodani, E. Zarei, A. Asadollahi (2013)
Sexual Abuse and Drug Abuse Among Homeless Children in Ahvaz, IranChild Abuse Review, 22
Injecting drug use addiction is a main factor in hepatitis B, C infection and HIV–AIDS infection. The purpose of this paper is to measure seroprevalence of hepatitis B, C virus and HIV–AIDS amongst injecting drug users (IDUs) and its influencing factors.Design/methodology/approachThe cross-sectional method was used in mid-2017 in Ahwaz city, southwest Iran. In total, 133 IDUs, aged 29–71 years (mean age=48.21 ± 10.4), were chosen from Aria addiction treatment centre. The data were collected on demographic and behavioural characteristics. In addition, serum samples were screened for those diseases.FindingsIn a total of 131 IDUs, 2 (1.5 per cent) were HIV+, 16 (11.7 per cent) HCV+ and 8 (6.1 per cent) HBV+. There was a significant correlation between diseases and IDU. Results of multiple regression stated that IDU was a more predicting variable as β=0.76 and the model was able to predict 74.1 per cent of the variance, F (3, 35)=12.42, ρ<0.001, R2=0.741, OR=3.01, 95% CI [1.44, 3.83]. The synchronised pairwise effect of age, imprisonment and IDU with GLM analysis was significant, F (2, 114)=20.433, ρ<0.000, ηHCV+2=0.609, ηHBV+2=0.616, and ηHCV+2=0.612, λWilks’=0.056. The infection rate among IDUs was significant and the most important risk factor for these infections has been intravenous drug use, together with age of misusing and imprisonment.Research limitations/implicationsThe non-cooperation of two samples, lack of participation of three addiction rehabilitation centres in Ahwaz city, the end of cooperation in the first two months of the implementation of the plan, and the lack of consistency of the three serum samples in the cases (two cases) were limitations of the study.Practical implicationsBased on the results, the following suggestions could be presented: establishing “Intervention Clubs” for treatment in the peripheral urban areas for the participation of women drug users – the responsible organisation is Cultural and Social Deputy of Ahwaz Municipality Organisation. Integration of “Small Self-caring Groups” in Sepidar Women’s Penitentiary in the East Ahwaz region – the responsible organisation is Khuzistan Province Prisons Organisation (the southwestern Iranian prisons authority); constructing “Community-based Committees” to increase the level of social intervention – the responsible organisation is the Iran Drug Control Headquarters at Iranian Presidential Office; screening of injecting drug use in the populations at risk, especially girls and women in marginalised areas – the responsible organisation is Deputy Director of Prevention and Treatment of Addiction in the Iran Welfare and Rehabilitation Organisation; establishing an “Patient Treatment Center” in high-risk areas along with directing drug users and supervising the relevant authorities – the responsible organisation is Deputy Police Commander on Social Assistance; providing education to families involved with addiction in the “Neighborhood Parks” – the responsible organisation is Deputy for Health Affairs.Social implicationsThey are mixed with practical implications as well.Originality/valueThe comprehensive harm reduction plan and prison-related issues of IDUs with shared syringe along with the pairwise age and imprisonment need to consider the above factors.
Drugs and Alcohol Today – Emerald Publishing
Published: Aug 8, 2019
Keywords: Iran; Risk factors; HIV–AIDS; IDU; Mid-life and elderly; Viral hepatitis
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.